arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

ARS Pharmaceuticals, Inc.

SPRY

$6.16 ▲ +0.60 (+10.70%) at close

26 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

ARS Pharmaceuticals, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $611.7M

Dividend Yield —

Revenue Growth 184.5% ↗

Op. Margin -265.2% ↘

ROIC -30.1% ↘

FCF / Share $-0.45

Trailing P/E —

Price / Book 10.0x

FCF Yield —

Debt / Equity 1.57

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$22.68M

↑ +184.5% —

Net Income Profit after all expenses

$-60.62M

↓ -78.6% —

Operating Margin Operating profit as % of sales

-265.2%

↓ -79.6% 0th

FCF / Share Free cash flow per share

$-0.45

↓ -8.7% —

Long-Term Debt Long-term obligations

$96.52M

— +0.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	184.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2206%)	-67.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-944%)	1471.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+18295%)	3043.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+37942%)	—	—	—	4900.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+61150%)	N/M	—	—	-97.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1323%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-74.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-160.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-253.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-218.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-25.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	27.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	31.2% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	66.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	68.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	14.3% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	N/M	23.1% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-78.6% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-167.4% Weak ↑ Weak Improving Year-over-year change in net income	-258.6% Weak ↓ Weak Declining Year-over-year change in net income	-229.8% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-28.7% Weak ↓ Weak Declining Year-over-year change in net income	27.9% Excellent ↓ Excellent Declining Year-over-year change in net income	31.2% Excellent ↑ Excellent Improving Year-over-year change in net income	50.3% Excellent ↑ Excellent Improving Year-over-year change in net income	16.8% Good ↑ Good Improving Year-over-year change in net income	-170.6% Weak ↓ Weak Declining Year-over-year change in net income	39.3% Excellent ↓ Excellent Declining Year-over-year change in net income	N/M	21.1% Good ↑ Good Improving Year-over-year change in net income	66.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-30.6% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-179.1% Weak ↑ Weak Improving Year-over-year change in net income	-257.4% Weak Weak Year-over-year change in net income	-257.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	-8.7% Weak Weak Year-over-year change in free cash flow	—	—	—	-491.5% Weak Weak Year-over-year change in free cash flow	—	—	—	47.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	942.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	223.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	—	-24.6% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-265.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1868%)	-147.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1084%)	-163.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1191%)	-302.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2120%)	-466.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3209%)	54.5% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+263%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-267.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2327%)	-147.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1326%)	-157.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1412%)	-285.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2480%)	-425.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3647%)	57.7% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+381%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-198.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-154.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-145.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-252.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	48.2% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.20x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	2.44x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.43x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.45x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-30.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	14.5% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	11.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-117.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	7.3% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	6.5% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-20.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	13.4% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-10.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-7.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	75.9% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	—	-6.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-3.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-98.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-759%)	-36.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-341%)	-34.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-331%)	-23.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-256%)	-14.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	19.4% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+30%)	-9.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-5.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-4.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-3.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	-6.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-7.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-5.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-6.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	14.6% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	-8.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-146.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1076%)	-6.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-5.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	-5.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	10.4% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	7.5% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-50%)	8.2% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-45%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	1.57x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+162%)	0.84x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+41%)	0.65x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+9%)	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-26.23x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-2028.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1615.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	-141.68x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$72.20M	$55.06M	$36.67M	$-51.54M	$-39.86M	$-50.82M	$-39.66M	$-36.63M	$-56.01M	$-70.97M	$-60.53M	$-119.02M	$-87.86M	$-210.52M	$-203.22M	—	$-233.99M	$-60.06M	—	$-359.69M	$-374.20M	$-386.57M	—	—	—	—
Debt / EBITDA (x)	-1.60x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.32x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.81x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.23	—	$0.33	$0.16	$0.08	—	$0.02	$0.01	$0.00	—	$0.00	$0.00	$0.00	—	—	$0.02	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.61	$-0.42	$-0.52	$-0.46	$-0.35	$0.51	$-0.20	$-0.13	$-0.11	$-0.07	$-0.16	$-0.18	$-0.16	$-0.21	$-0.50	$-0.21	—	$1.19	$-0.65	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.45	—	$-0.48	$-0.40	$-0.42	—	—	—	$-0.07	—	—	—	$-0.13	—	—	$-0.23	—	—	$-0.55	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.62	$1.15	$1.49	$1.95	$2.33	$2.62	$2.07	$2.22	$2.32	$2.39	$2.48	$2.61	$2.77	$2.90	$7.44	$-1.44	$8.35	$-1.03	$9.49	$10.00	$10.58	$11.03	—	—	—	—
Tangible Book Value per Share (USD)	$0.47	$1.01	$1.34	$1.82	$2.26	$2.55	$1.99	$2.22	$2.32	$2.39	$2.48	$2.61	$2.77	$2.90	$7.44	$-1.44	$8.35	$-1.03	$9.49	$10.00	$10.58	$11.03	—	—	—	—
Basic Weighted Avg Shares (shares)	99.30M	—	98.81M	98.36M	98.06M	—	97.03M	96.83M	96.49M	—	95.58M	94.91M	94.23M	—	35.46M	30.61M	—	—	35.00M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$195.62M	$245.75M	$287.99M	$235.84M	$276.24M	$310.86M	$192.17M	$214.01M	$222.53M	$229.34M	$233.29M	$244.98M	$257.51M	$272.26M	$266.81M	—	$246.52M	$52.54M	—	$347.48M	$366.75M	$381.06M	—	—	—	—
LT Debt (USD)	$96.52M	$96.37M	$96.23M	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$61.31M	$114.26M	$147.66M	$192.32M	$228.97M	$256.80M	$200.98M	$215.24M	$223.87M	$230.76M	$237.28M	$248.55M	$261.15M	$272.89M	$267.07M	$-44.03M	$293.23M	$-31.27M	$332.13M	$349.65M	$368.55M	$382.88M	$-78.25M	$-70.34M	$-64.00M	$-58.78M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$22.68M	$28.09M	$32.50M	$15.72M	$7.97M	$86.58M	$2.07M	$500.00K	$0.00	$0.00	$0.00	$10.00K	$20.00K	$0.00	—	$464.00K	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	—	—	$21.00K	$18.00K	$11.00K	$12.00K	—	—	$20.00K	$14.00K	—	$-37.00K	—	—	$201.00K	—	$186.00K	$189.00K	$171.00K	$138.00K	$139.00K	—
Net Income, GAAP (USD)	$-60.62M	$-41.32M	$-51.15M	$-44.88M	$-33.94M	$49.93M	$-19.13M	$-12.52M	$-10.29M	$-7.17M	$-14.87M	$-17.37M	$-14.96M	$-14.43M	$-17.86M	$-6.42M	$-24.63M	$45.77M	$-22.66M	$-18.87M	$-18.87M	$-13.09M	$-8.12M	$-5.28M	$-5.28M	—
Operating Cash Flow (USD)	$-44.95M	$-43.48M	$-47.05M	$-39.59M	$-40.74M	$42.00M	—	—	$-6.71M	$-17.41M	—	—	$-12.43M	$-20.50M	—	$-6.97M	$-19.74M	$27.89M	$-19.12M	—	$-12.20M	$-11.10M	$-7.03M	$-5.44M	$-7.63M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

ARS Pharmaceuticals, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SPRY with peers